The Daily Brief India’s CDMO surge: The business behind the Drugs
May 30, 2025
Discover India's booming CDMO sector and its pivotal role in the global pharmaceutical landscape. Delve into the economic disparities and challenges hindering manufacturing growth. Unpack the factors limiting India's competitiveness against Southeast Asia, including high tariffs and trade barriers. The conversation emphasizes the need for introspection and strategic reforms to unlock India's potential as a global economic powerhouse.
AI Snips
Chapters
Transcript
Episode notes
India's Rising Pharma CDMO Role
- India's CDMO sector supports global pharma by developing and manufacturing drugs under other companies' brands.
- CDMOs combine science, safety, and strict regulation to deliver reliable pharma production worldwide.
Divi's: Complex Pharma Innovator
- Divi's Labs excels in complex drug ingredients and peptide APIs with strong global contracts.
- They maintain supply chain reliability despite global logistics disruptions, reinforcing their competitive strength.
Akams: India's Domestic Pharma Engine
- Akams powers India's domestic pharma by outsourcing manufacturing for many generic drug brands.
- They're expanding into injectables and international markets with new facilities and European audits.